Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs
Saini, R.K.; Antonaccio, M.J.
Journal of Pharmacology and Experimental Therapeutics 221(1): 29-36
1982
ISSN/ISBN: 0022-3565 PMID: 7062289 Document Number: 197031
Document emailed within 1 workday
Related Documents
de la Coussaye, J.E.; Bassoul, B.; Bruelle, P.; Peray, P.A.; Albat, B.; Gagnol, J.P.; Daures, J.P.; Eledjam, J.J.; Sassine, A. 1992: Reduction by carbachol of ventricular conduction impairments induced by various class I antiarrhythmic drugs in anesthetized dogs Archives Internationales de Pharmacodynamie et de Therapie 315: 47-62Saini, R.K.; Fulmor, I.E.; Parham, C.S.; Antonaccio, M.J. 1986: Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 237(1): 1-8
Karasawa, A.; Kubo, K.; Shuto, K.; Oka, T.; Nakamizo, N. 1988: Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats Arzneimittel-Forschung 38(11a): 1707-1712
Eigenmann, R.; Blaber, L.; Nakamura, K.; Thorens, S.; Haeusler, G. 1981: Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies Arzneimittel-Forschung 31(9): 1393-1401
Opie, L.H.; Muller, C.A.; Thandroyen, F.T.; Lloyd, E.A.; Mabin, T.; Commerford, P.J.; Eichler, H.G. 1985: Tiapamil--a new calcium antagonist South African Medical Journal 67(22): 881-883
Ericsson, H.; Tholander, B.; Björkman, J.A.; Nordlander, M.; Regårdh, C.G. 1999: Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(5): 558-564
Menzel, T.; Kirchner, P.; Cocco, G.; Gasser, D.F. 1981: Management of supraventricular and ventricular arrhythmias with the intravenous administration of the calcium antagonist Tiapamil (Ro 11-1781) Zeitschrift für Kardiologie 70(3): 163-171
Patterson, E.; Montgomery, D.G.; Lynch, J.J.; Lucchesi, B.R. 1984: Cardiac electrophysiologic actions of KB-944 (Fostedil), a new calcium antagonist, in the anesthetized dog Journal of Pharmacology and Experimental Therapeutics 230(3): 632-640
Shargorodskii, B.M.; Kats, I.A. 1973: The possible relationship between the antifibrillatory effect of inderal in experimental myocardial infarct and its effect on cardiac oxidation reduction processes and blood supply Kardiologiia 13(3): 81-87
Sasao, J.; Taneyama, C.; Kimura, M.; Kiyono, S. 1989: The effects of ONO 3708, a new thromboxane receptor antagonist, on cardiovascular response during the early phases of endotoxin shock in anesthetized dogs Masui. Japanese Journal of Anesthesiology 38(9): 1188-1194
Alexanian, A.R.; Arutyunian, N.S.; Galoyan, A.A. 1996: Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride Arzneimittel-Forschung 46(12): 1110-1113
Urban, P.; Gold, H.K.; Goldberg, S. 1983: Reduction of infarct size with thrombolytic agents Cardiovascular Clinics 14(1): 203-215
Dvorák, K.; Vavros, B.; Cerný, J. 1975: Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect Vnitrni Lekarstvi 21(3): 278-284
Lazar, H.L.; Haan, C.K.; Yang, X.; Rivers, S.; Bernard, S.; Shemin, R.J. 1992: Reduction of infarct size with coronary venous retroperfusion Circulation 86(5): Ii352-Ii357
Nakaya, H.; Kanno, M.; Kanda, K.; Oyama, Y. 1980: Electrophysiologic effects of calcium channel blocking agents on the sinus node function in anesthetized dogs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(8): 697-707
Rao, M.R.; Liang, M.D.; Liu, G.Y.; Liu, F.; Zhang, H.Q. 1984: Effect of m-nifedipine, a calcium antagonist, on cardiac performance and oxygen consumption in anesthetized animal: a comparison with nifedipine Yao Xue Xue Bao 19(2): 101-107
Higo, K.; Sano, J.; Karasawa, A.; Kubo, K. 1993: The novel thromboxane A2 receptor antagonist KW-3635 reduces infarct size in a canine model of coronary occlusion and reperfusion Archives Internationales de Pharmacodynamie et de Therapie 323: 32-49
Säfholm, C.; Havu, N. 1993: General toxicity of the new calcium antagonist felodipine in dogs Arzneimittel-Forschung 43(7): 729-733
Bussmann, W.D.; Passek, D.; Seidel, W.; Klepzig, H.; Kaltenbach, M. 1980: Reduction of CK and CK-MB enzyme levels as indicators of infarct size by intravenous nitroglycerin Zeitschrift für Kardiologie 69(1): 18-30
Singh, B.N.; Smith, H.J.; Norris, R.M. 1975: Reduction in infarct size following experimental coronary occlusion by administration of verapamil Recent Advances in Studies on Cardiac Structure and Metabolism 10: 435-452